Precision BioSciences, Inc. (DTIL)
NASDAQ: DTIL · Real-Time Price · USD
7.10
+0.06 (0.85%)
At close: Apr 28, 2026, 4:00 PM EDT
6.89
-0.21 (-2.96%)
After-hours: Apr 28, 2026, 7:34 PM EDT
Precision BioSciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 34.26 | 68.7 | 48.73 | 25.1 | 115.53 | Upgrade
|
| Revenue Growth (YoY) | -50.12% | 40.98% | 94.15% | -78.28% | 375.72% | Upgrade
|
| Gross Profit | 34.26 | 68.7 | 48.73 | 25.1 | 115.53 | Upgrade
|
| Selling, General & Admin | 32.24 | 35.3 | 39.09 | 43.34 | 43.23 | Upgrade
|
| Research & Development | 54.17 | 59.56 | 53.38 | 44.07 | 111.68 | Upgrade
|
| Operating Expenses | 86.41 | 94.86 | 92.46 | 87.41 | 154.91 | Upgrade
|
| Operating Income | -52.15 | -26.16 | -43.74 | -62.31 | -39.38 | Upgrade
|
| Interest Expense | -1.42 | -1.78 | -2.23 | -1.11 | -0.13 | Upgrade
|
| Interest & Investment Income | 4.24 | 6.76 | 7.69 | 3.47 | 0.21 | Upgrade
|
| Earnings From Equity Investments | -5.28 | -1.08 | -4.93 | -1.58 | 0.18 | Upgrade
|
| Other Non Operating Income (Expenses) | 11.13 | 29.61 | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | -43.49 | 7.35 | -43.21 | -61.53 | -39.12 | Upgrade
|
| Gain (Loss) on Sale of Investments | -2.67 | 0.26 | 1.15 | -0.51 | 2.56 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.42 | -0.44 | -0.46 | -0.03 | 5.96 | Upgrade
|
| Asset Writedown | -0.04 | - | - | -10.84 | - | Upgrade
|
| Pretax Income | -46.61 | 7.17 | -42.53 | -72.91 | -30.6 | Upgrade
|
| Earnings From Continuing Operations | -46.61 | 7.17 | -42.53 | -72.91 | -30.6 | Upgrade
|
| Earnings From Discontinued Operations | 0.89 | - | -18.79 | -38.73 | - | Upgrade
|
| Net Income | -45.72 | 7.17 | -61.32 | -111.64 | -30.6 | Upgrade
|
| Net Income to Common | -45.72 | 7.17 | -61.32 | -111.64 | -30.6 | Upgrade
|
| Shares Outstanding (Basic) | 13 | 7 | 4 | 3 | 2 | Upgrade
|
| Shares Outstanding (Diluted) | 13 | 7 | 4 | 3 | 2 | Upgrade
|
| Shares Change (YoY) | 86.32% | 79.20% | 31.11% | 49.77% | 12.79% | Upgrade
|
| EPS (Basic) | -3.56 | 1.05 | -15.96 | -38.10 | -15.64 | Upgrade
|
| EPS (Diluted) | -3.56 | 1.04 | -15.96 | -38.10 | -15.64 | Upgrade
|
| Free Cash Flow | -65.93 | -58.7 | -86.07 | -49.07 | -15.91 | Upgrade
|
| Free Cash Flow Per Share | -5.14 | -8.53 | -22.41 | -16.75 | -8.13 | Upgrade
|
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | Upgrade
|
| Operating Margin | -152.19% | -38.08% | -89.76% | -248.26% | -34.08% | Upgrade
|
| Profit Margin | -133.45% | 10.43% | -125.84% | -444.80% | -26.49% | Upgrade
|
| Free Cash Flow Margin | -192.41% | -85.44% | -176.64% | -195.52% | -13.77% | Upgrade
|
| EBITDA | -50.68 | -22.76 | -36.92 | -54.51 | -30.4 | Upgrade
|
| EBITDA Margin | -147.91% | -33.13% | -75.77% | -217.19% | -26.31% | Upgrade
|
| D&A For EBITDA | 1.47 | 3.4 | 6.82 | 7.8 | 8.98 | Upgrade
|
| EBIT | -52.15 | -26.16 | -43.74 | -62.31 | -39.38 | Upgrade
|
| EBIT Margin | -152.19% | -38.08% | -89.76% | -248.26% | -34.08% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.